Scotland’s NHS to fund Ipsen cancer diarrhoea drug
Decision welcomed as step forward for patients
X
Scotland’s NHS to fund Ipsen cancer diarrhoea drug
https://pharmaphorum.com/news/scotlands-nhs-ipsen-cancer-drug/
Ipsen
EU approves Ipsen’s Cabometyx in first line kidney cancer
Drug looks set to become core part of Ipsen’s cancer offering
Ipsen takes on BMS as kidney cancer pill launches in EU
Cabometyx could take market share from Opdivo
NICE recommends funding for three thyroid cancer drugs
Eisai’s drug finally funded after two year delay
Hear from MedImmune and Ipsen at SMi’s Injectable Drug Delivery 2018
Launch of Injectable Drug Delivery
Ipsen presents on oral peptides innovations, advances and delivery
Ipsen presents on oral peptides innovations & delivery
NICE wants to axe funding for two thyroid cancer drugs
NICE unconvinced by survival data from Ipsen and Sanofi drugs
CEO Meek looks to boost Ipsen with drug acquisitions
Could French biotech snap up remaining rights to pancreatic cancer drug?
1 2
